Work

Insulin-like growth factor-1 receptor (IGF-1R/CD221): A target for monoclonal antibody-based therapy to overcome drug-resistance in multiple myeloma (MM), other hematologic malignancies and solid tumors

Year: 2004

Type: article

Source: Cancer Research

Authors: Constantine S. Mitsiades, Nicholas Mitsiades, Ciaran J. McMullan, Reshma Shringarpure, Rajeeva Singh, Kenneth C. Anderson

Institutions: Harvard University, Dana-Farber Cancer Institute, Dana-Farber/Harvard Cancer Center

Language: English

Topic: Growth Hormone and Insulin-like Growth Factors

Subfield: Endocrinology, Diabetes and Metabolism

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3035314213

FWCI:

Cites:

Cited by:

Related to: 10